Homonymous Hemianopia Open Access to Scientific and Medical Research DOI
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cory Newman Thesis 5-2021 Signed.Pdf (1.303Mb)
DocuSign Envelope ID: 4851A328-CF63-4770-A833-B4246E7E5D23 Simulating Homonymous Hemianopsia for the Care Team by Cory Newman May 2021 Presented to the Division of Science, Information Arts, and Technologies University of Baltimore In Partial Fulfillment of the Requirements for the Degree of Master of Science 5/25/2021 Approved by: ________________________________ [name, Thesis Advisor] ________________________________5/25/2021 [name, Committee Member] i DocuSign Envelope ID: 4851A328-CF63-4770-A833-B4246E7E5D23 Abstract Homonymous hemianopsia is a visual impairment that involves the bilateral loss of a complete visual field. While research has been done to ascertain the details of cause and prognosis of homonymous hemianopsia, an obvious disparity arose in the research on how to educate the supporting care team of a person with homonymous hemianopsia to maximize the creation of educational and rehabilitation plans. This research presents two studies focused on closing that gap by providing an alternative method of understanding. In the initial study 16 participants with a confirmed caregiver relationship to one or more persons with homonymous hemianopsia were surveyed on their personal knowledge of the visual impairment. These participants were asked to express any visual obstacles they have encountered, and to ascertain the availability of a device or program that could provide an interactive interpretation of how their homonymous hemianopsia patient views their surroundings. Survey results confirmed the need for a program that could easily simulate homonymous hemianopsia for the care provider. An additional usability study was completed by eight of the 16 previous participants on a mobile homonymous hemianopsia simulation application prototype. User tests showed that participants gained a significant increase in understanding of how those with a homonymous hemianopsia visual impairment view the environment. -
Homonymous Hemianopsia
Source: CLEVELAND CLINIC OHIO USA FACTSHEET Homonymous Hemianopsia Homonymous hemianopsia is a condition in which a person sees only one side - right or left of the visual world of each eye; results from a problem in brain function rather than a disorder of the eyes themselves. This can happen after a head or brain injury. What is homonymous hemianopsia? Homonymous hemianopsia is a condition in which a person sees only one side―right or left―of the visual world of each eye. The person may not be aware that the vision loss is happening in both eyes, not just one. Under normal circumstances, the left half of the brain processes visual information from both eyes about the right side of the world. The right side of the brain processes visual information from both eyes about the left side of the world. A visual world of someone with normal vision A visual world of someone with homonymous hemianopsia In homonymous hemianopsia, an injury to the left part of the brain results in the loss of the right half of the visual world of each eye. An injury to the right part of the brain produces loss of the left side of the visual world of each eye. This condition is created by a problem in brain function rather than a disorder of the eyes themselves. What causes homonymous hemianopsia? The most common cause of this type of vision loss is stroke. However, any disorder that affects the brain—including tumours, inflammation, and injuries--can be a cause. Source: CLEVELAND CLINIC OHIO USA It is estimated that 70% of the injuries leading to hemianopsias are due to an obstruction (blockage) of the blood supply (stroke). -
Customer Vision Report (MED 4)
MED 4 (11/25/2020) CUSTOMER VISION REPORT Purpose: Use this form to request vision examination information from your ophthalmologist or optometrist. Instructions: Complete the Customer Information section and have your Ophthalmologist/Optometrist complete the Vision Examination section. The vision examination must be conducted within 90 days prior to submission of the report to DMV. Mail the completed report to the address above. Questions can be referred to Medical Review Services, 804-367-6203. Acceptable standards of vision for safe driving are determined by the Code of Virginia and DMV under the guidance of the Medical Advisory Board. Note: Any charges incurred for the completion of this form are your responsibility. CSC STAFF Do NOT send MED 4 back with daily work unless there is an ocular condition or customer cannot be licensed due to a MED 6 calculation. CUSTOMER INFORMATION (To be completed by customer PRIOR to vision examination) If you change either your residence/home address or mailing address to a non-Virgina address, your driver license or photo identification (ID) card may be cancelled. NAME (last) (first) (mi) (suffix) CUSTOMER NUMBER (from your driver license) or SSN RESIDENCE/HOME ADDRESS BIRTHDATE (mm/dd/yyyy) CITY STATE ZIP CODE CITY OR COUNTY OF RESIDENCE MAILING ADDRESS (if different from above) CITY STATE ZIP CODE DAYTIME TELEPHONE NUMBER VISION EXAMINATION (to be completed by Ophthalmologist/Optometrist) FIRST EXAMINATION DATE MOST RECENT EXAMINATION DATE Does the patient have any visual/ocular condition(s) that could affect the ability to drive a motor vehicle? YES NO If YES, indicate condition below. -
Oct Institute
Low Vision, Visual Dysfunction and TBI – Treatment, Considerations, Adaptations Andrea Hubbard, OTD, OTR/L, LDE Objectives • In this course, participants will: 1. Learn about interventions involving specialized equipment to adapt an environment for clients with low vision. 2. Learn about the most typical low vision presentations/conditions. 3. Gain increased knowledge of eye anatomy and the visual pathway. Overview of TBI Reference: Centers for Disease Control and Prevention Overview of TBI Risk Factors for TBI Among non-fatal TBI-related injuries for 2006–2010: • Men had higher rates of TBI hospitalizations and ED visits than women. • Hospitalization rates were highest among persons aged 65 years and older. • Rates of ED visits were highest for children aged 0-4 years. • Falls were the leading cause of TBI-related ED visits for all but one age group. – Assaults were the leading cause of TBI-related ED visits for persons 15 to 24 years of age. • The leading cause of TBI-related hospitalizations varied by age: – Falls were the leading cause among children ages 0-14 and adults 45 years and older. – Motor vehicle crashes were the leading cause of hospitalizations for adolescents and persons ages 15-44 years. Reference: Centers for Disease Control and Prevention Overview of TBI Risk Factors for TBI Among TBI-related deaths in 2006–2010: • Men were nearly three times as likely to die as women. • Rates were highest for persons 65 years and older. • The leading cause of TBI-related death varied by age. – Falls were the leading cause of death for persons 65 years or older. -
Boosting Learning Efficacy with Non-Invasive Brain Stimulation in Intact and Brain-Damaged Humans
This Accepted Manuscript has not been copyedited and formatted. The final version may differ from this version. Research Articles: Behavioral/Cognitive Boosting learning efficacy with non-invasive brain stimulation in intact and brain-damaged humans F. Herpich1,2,3, F. Melnick, M.D.4 , S. Agosta1 , K.R. Huxlin4 , D. Tadin4 and L Battelli1,5,6 1Center for Neuroscience and Cognitive Systems@UniTn, Istituto Italiano di Tecnologia, Corso Bettini 31, 38068 Rovereto (TN), Italy 2Center for Mind/Brain Sciences, University of Trento, 38068 Rovereto, Italy 3kbo Klinikum-Inn-Salzach, Gabersee 7, 83512, Wasserburg am Inn, Germany 4Department of Brain and Cognitive Sciences, Flaum Eye Institute and Center for Visual Science, University of Rochester, Rochester, NY, USA 5Berenson-Allen Center for Noninvasive Brain Stimulation and Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, 02215 Massachusetts, USA 6Cognitive Neuropsychology Laboratory, Harvard University, Cambridge, MA, USA https://doi.org/10.1523/JNEUROSCI.3248-18.2019 Received: 28 December 2018 Revised: 10 April 2019 Accepted: 8 May 2019 Published: 27 May 2019 Author contributions: F.H., M.D.M., K.H., D.T., and L.B. designed research; F.H., M.D.M., and S.A. performed research; F.H., M.D.M., and D.T. analyzed data; F.H., M.D.M., and L.B. wrote the first draft of the paper; M.D.M., S.A., K.H., D.T., and L.B. edited the paper; K.H., D.T., and L.B. wrote the paper. Conflict of Interest: The authors declare no competing financial interests. The present study was funded by the Autonomous Province of Trento, Call “Grandi Progetti 2012”, project “Characterizing and improving brain mechanisms of attention — ATTEND (FH, SA, LB), “Fondazione Caritro — Bando Ricerca e Sviluppo Economico” (FH), NIH (DT, MM and KRH: R01 grants EY027314 and EY021209, CVS training grant T32 EY007125), and by an unrestricted grant from the Research to Prevent Blindness (RPB) Foundation to the Flaum Eye Institute. -
Read PDF Edition
REVIEW OF OPTOMETRY EARN 2 CE CREDITS: Positive Visual Phenomena—Etiologies Beyond the Eye, PAGE 58 ■ VOL. 155 NO. 1 January 15, 2018 www.reviewofoptometry.comwww.reviewofoptometry.com ■ ANNUAL CORNEA REPORT JANUARY 15, 2018 ■ CXL ■ EPITHELIAL DEFECTS How to Heal Persistent Epithelial Defects PAGE 38 ■ TRANSPLANTS Corneal Transplants: The OD’s Role PAGE 44 ■ INFILTRATES Diagnosing Corneal Infiltrative Disease PAGE 50 ■ POSITIVE VISUAL PHENOMENA CXL: Your Top 12 Questions —Answered! PAGE 30 001_ro0118_fc.indd 1 1/5/18 4:34 PM ĊčĞĉėĆęĊĉĆĒēĎĔęĎĈĒĊĒćėĆēĊċĔėĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊĘ ĊđĎĊċĎēĘĎČčę ċċĊĈęĎěĊ Ȉ 1 Ȉ 1 ĊđđǦęĔđĊėĆęĊĉ Ȉ Ȉ ĎĒĕđĊĎēǦĔċċĎĈĊĕėĔĈĊĉĚėĊ Ȉ Ȉ ĔēěĊēĎĊēę Ȉ͝ Ȉ Ȉ Ƭ 1 ǡ ǡǡǤ͚͙͘͜Ǥ Ȁ Ǥ ͚͙͘͜ǣ͘͘ǣ͘͘͘Ǧ͘͘͘ ĕĕđĎĈĆęĎĔēĘ Ȉ Ȉ Ȉ Ȉ Ȉ čĊĚėĎĔē̾ėĔĈĊĘĘ Ȉ Ȉ Katena — Your completecomplete resource forfor amniotic membrane pprocedurerocedure pproducts:roducts: Single use speculums Single use spears ͙͘͘ǡ͘͘͘ήĊĞĊĘęėĊĆęĊĉ Forceps ® ,#"EWB3FW XXXLBUFOBDPNr RO0118_Katena.indd 1 1/2/18 10:34 AM News Review VOL. 155 NO. 1 ■ JANUARY 15, 2018 IN THE NEWS Accelerated CXL Shows The FDA recently approved Luxturna (voretigene neparvovec-rzyl, Spark Promise—and Caution Therapeutics), a directly administered gene therapy that targets biallelic This new technology is already advancing, but not without RPE65 mutation-associated retinal dystrophy. The therapy is designed to some bumps in the road. deliver a normal copy of the gene to By Rebecca Hepp, Managing Editor retinal cells to restore vision loss. While the approval provides hope for patients, wo new studies highlight the resulted in infection—while tradi- the $425,000 per eye price tag stands as pros and cons of accelerated tional C-CXL has a reported inci- a signifi cant hurdle. -
Mechanisms Compensating for Visual Field Restriction in Adolescents With
Eye (2012) 26, 1437–1445 & 2012 Macmillan Publishers Limited All rights reserved 0950-222X/12 www.nature.com/eye 1;2 3;4 1 Mechanisms L Jacobson , F Lennartsson , T Pansell ,GO¨ qvist CLINICAL STUDY Seimyr2 and L Martin2;5 compensating for visual field restriction in adolescents with damage to the retro-geniculate visual system 1Eye Unit, Department of Neuropaediatrics, Astrid Lindgren Children’s Hospital, Karolinska University Abstract Hospital, Stockholm, Background To describe visual field (VF) Conclusion Congenital and later-acquired Sweden outcome in three adolescents with damage to homonymous VF defects may, at least in 2 the optic radiation and to focus on young subjects, be compensated for by Department of Clinical Neuroscience, mechanisms that may compensate the scanning. Exotropia may compensate VF Ophthalmology and Vision, practical functional limitations of VF defects. defects and, therefore, the VF should be Karolinska Institutet, Design Descriptive, prospective multi-case tested before strabismus surgery. Stockholm, Sweden study in a hospital setting. Eye (2012) 26, 1437–1445; doi:10.1038/eye.2012.190; Participants Three teenagers with cerebral published online 21 September 2012 3Department of Medical visual dysfunction because of damage to the Physics, Karolinska University Hospital, retro-geniculate visual pathways. Keywords: VF defects; retro-geniculate visual Stockholm, Sweden Methods Best-corrected visual acuity and system; compensating mechanisms; eye alignment were assessed. Visual field adolescents 4Department of function was tested with Goldmann Neuroradiology, Karolinska perimetry, and with Rarebit, Humphrey University Hospital, Introduction Visual Field Analyzer and Esterman Stockholm, Sweden computerized techniques. Fixation was Brain damage has become the most common 5School of Health and registered with video oculography during cause of visual impairment in children in Welfare, Ma¨ lardalen 1–3 Rarebit examination. -
Case Report: Superior Homonymous Quadrantanopia in a Patient with an Infective Endocarditis
Case Report: Superior homonymous quadrantanopia in a patient with an infective endocarditis Jennifer Nim, O.D. Long Island, New York, [email protected] An infective endocarditis, specifically bacterial endocarditis, is usually caused by bacteria carried in the blood that may originate from an infection in other parts of the body besides the heart.1 Injuries, surgeries or preexisting heart conditions make the body vulnerable to infections. Emboli may arise during this type of infection that may lead to visual field defects. Case Report A 62-year-old white male from New York presented with the primary complaint of a recent loss of his left peripheral vision in his left eye and moving white and red flashes in both eyes. The patient had a history of floaters which have subsided in the past years. In addition, the patient reported an acute loss of hearing. The patient denies any head trauma, slurred speech or paralysis in the limbs. Medical history revealed hypercholesteremia and hypertension, for which he takes vytorin and lotrel, respectively. The patient’s best-corrected visual acuities were 20/20 in the right eye (OD) and in the left eye (OS). Pupil and extraocular motility testings were normal. Slit lamp evaluation revealed trace arcus and cortical cataracts in both eyes (OU). Intraocular pressures were within normal ranges in OU. The dilation fundus examination revealed posterior vitreal detachments in OU and a flat, choroidal nevus in the OD. The posterior pole (see Figures 1) and peripheral retina were flat and intact in OU. An automated threshold visual field revealed left superior homonymous quandrantanopia that respected the vertical line but not the horizontal line (see Figures 2). -
Embryology, Anatomy, and Physiology of the Afferent Visual Pathway
CHAPTER 1 Embryology, Anatomy, and Physiology of the Afferent Visual Pathway Joseph F. Rizzo III RETINA Physiology Embryology of the Eye and Retina Blood Supply Basic Anatomy and Physiology POSTGENICULATE VISUAL SENSORY PATHWAYS Overview of Retinal Outflow: Parallel Pathways Embryology OPTIC NERVE Anatomy of the Optic Radiations Embryology Blood Supply General Anatomy CORTICAL VISUAL AREAS Optic Nerve Blood Supply Cortical Area V1 Optic Nerve Sheaths Cortical Area V2 Optic Nerve Axons Cortical Areas V3 and V3A OPTIC CHIASM Dorsal and Ventral Visual Streams Embryology Cortical Area V5 Gross Anatomy of the Chiasm and Perichiasmal Region Cortical Area V4 Organization of Nerve Fibers within the Optic Chiasm Area TE Blood Supply Cortical Area V6 OPTIC TRACT OTHER CEREBRAL AREASCONTRIBUTING TO VISUAL LATERAL GENICULATE NUCLEUSPERCEPTION Anatomic and Functional Organization The brain devotes more cells and connections to vision lular, magnocellular, and koniocellular pathways—each of than any other sense or motor function. This chapter presents which contributes to visual processing at the primary visual an overview of the development, anatomy, and physiology cortex. Beyond the primary visual cortex, two streams of of this extremely complex but fascinating system. Of neces- information flow develop: the dorsal stream, primarily for sity, the subject matter is greatly abridged, although special detection of where objects are and for motion perception, attention is given to principles that relate to clinical neuro- and the ventral stream, primarily for detection of what ophthalmology. objects are (including their color, depth, and form). At Light initiates a cascade of cellular responses in the retina every level of the visual system, however, information that begins as a slow, graded response of the photoreceptors among these ‘‘parallel’’ pathways is shared by intercellular, and transforms into a volley of coordinated action potentials thalamic-cortical, and intercortical connections. -
VISUAL FIELD Pathway Extends from the „Front‟ to the „Back‟ of the RETINA Brain
NOTE: To change the image on this slide, select the picture and delete it. Then click the Pictures icon in the placeholde r to insert your own image. Visual Pathway Disorders Amr Hassan, MD, FEBN Associate professor of Neurology - Cairo University Optic nerve • Anatomy of visual pathway • How to examine • Visual pathway disorders • Quiz 2 Optic nerve • Anatomy of visual pathway • How to examine • Visual pathway disorders • Quiz 3 Optic nerve The Visual Pathway VISUAL FIELD Pathway extends from the „front‟ to the „back‟ of the RETINA brain. ON OC OT LGN OPTIC RADIATIONS ON = Optic Nerve OC = Optic Chiasm OT = Optic Tract LGN = Lateral Geniculate Nucleus of Thalamus VISUAL CORTEX 5 The Visual Pathway Eyes & Retina Light >> lens >> retina (inverted and reversed image). Eyes & Retina Eyes & Retina • Macula: oval region approximately 3-5 mm that surrounds the fovea, also has high visual acuity. • Fovea: central fixation point of each eye// region of the retina with highest visual acuity. Eyes & Retina • Optic disc: region where axons leaving the retina gather to form the Optic nerve. Eyes & Retina • Blind spot located 15° lateral and inferior to central fixation point of each eye. Object to be seen Peripheral Retina Central Retina (fovea in the macula lutea) 12 Photoreceptors © Stephen E. Palmer, 2002 Photoreceptors Cones • Cone-shaped • Less sensitive • Operate in high light • Color vision • Less numerous • Highly represented in the fovea >> have high spatial & temporal resolution >> they detect colors. © Stephen E. Palmer, 2002 Photoreceptors Rods • Rod-shaped • Highly sensitive • Operate at night • Gray-scale vision • More numerous than cons- 20:1, have poor spatial & temporal resolution of visual stimuli, do not detect colors >> vision in low level lighting conditions © Stephen E. -
SEMPHN Pathways
Sudden or Recent Vision Loss Disclaimer COVID-19 note The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) and The Royal Australian College of General Practitioners (RACGP) have made recommendations regarding eye examination during the COVID-19 pandemic. See RANZCO – COVID-19: Practical Guidance for General Practitioners Performing Eye Examinations. Last updated: 18 May 2020 Contents Disclaimer ......................................................................................................................................................................................... 1 Red Flags .................................................................................................................................................... 2 Background – About Sudden or Recent Vision Loss ............................................................................. 2 Assessment ................................................................................................................................................ 2 Management ............................................................................................................................................. 7 Practice Point .................................................................................................................................................................................. 7 Referral ...................................................................................................................................................... -
Visual Problems After Brain Injury
Visual problems after brain injury As a charity, we rely on donations from people like you to continue providing free information to people affected by brain injury. Donate today: www.headway.org.uk/donate Introduction Vision is the skill that allows us to see the world around us. When we look at the world, a complex series of processes takes place between the eyes and the brain. The eyes take in the information, while the brain (which is connected to the eyes by a nerve called the optic nerve) is responsible for processing and interpreting it. Through this system we are able to see things such as colours, shapes, movement, objects and people. When the brain is injured, the ability to interpret visual information can be affected in different ways. This factsheet has been written to explain how brain injury can affect vision and how to seek professional support with these issues. Tips for coping with visual problems are also offered. Words in bold are defined in a glossary at the end of the factsheet. What is vision? There are lots of different aspects of vision. Some of the things the brain needs to do to decode information that it receives from the eyes are: • process the shape and colour of objects • process and merge information received from both eyes • recall information from memory to recognise objects or places • process the movement of objects • process the location and position of an object in space • process information across the visual field (including peripheral vision) Generally, different parts of the brain are responsible for processing these different aspects of vision.